| Code | 1032A | ||||||||||
| MA number | 65/0237/12-S | ||||||||||
| Product Form: | tbl 40x37,5 mg/325 mg (blis.priehľ.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 65 - ANALGETICA - ANODYNA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister transparent PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.04.2012 |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Tramapran 37,5 mg_325 mg_10.2022.pdf
|
| PIL: |
PIL_Tramapran 37,5 mg_325mg_10.2022.pdf
|
| Safety feature | Yes |
| Data update: | 21.02.2019 |
